Michael Granberry, MD
Orthopaedic Surgery · Mobile, ALNPI 1427058882
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Pacira Therapeutics, Inc. accounts for 60.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $2,617 and has fallen 93.0% since, to $184 in 2024.
Across 84 payments — averaging $51.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$3K
- Johnson & Johnson$333
- Zimmer Biomet$297
- Amgen$166
- Si-bone, Inc.$117
- DJO, LLC$116
- plus $708 from 14 others
Across 6 payments — averaging $6191.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$25K
- Pacira Therapeutics, Inc.$12K
What the payments were for
- Speaking & faculty fees$2,39355%
- Travel & lodging$822%
- Food & beverage$1,88243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 15 | $2,621 |
| Johnson & Johnson(2 entities) | 8 | $333 |
| Zimmer Biomet | 10 | $297 |
| Amgen(2 entities) | 12 | $166 |
| Si-bone, Inc. | 4 | $117 |
| DJO, LLC | 3 | $116 |
| Heraeus Medical, LLC. | 5 | $106 |
| Baxter Healthcare | 5 | $105 |
| Radius Health, Inc. | 6 | $100 |
| Stryker | 2 | $89 |
| Davol Inc. | 1 | $60 |
| Kowa Pharmaceuticals America, Inc. | 4 | $57 |
| BD | 1 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Kerecis Limited | 1 | $23 |
| Vertex | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Vericel Corporation | 1 | $16 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,357 in reported general payments places this provider in the 60th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 588 | $7,547 |
| Naproxen | 441 | $3,676 |
| Diclofenac Sodium | 117 | $1,687 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 126 | $1,328 |
| Meloxicam | 375 | $1,294 |
| Cefadroxil | 156 | $1,280 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 101 | $674 |
| Ibuprofen | 28 | $411 |
| Clindamycin Hcl | 61 | $304 |
| Amoxicillin | 132 | $137 |
| Gabapentin | 27 | $129 |
| Tramadol Hcl | 20 | $67 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $66 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mobile
- Matthew BarberMobile$158K
- Joseph ZarzourMobile$68K
- Russell GoodeMobile$43K
- Jess MullensMobile$33K
- Clinton HowardMobile$24K
- Blake BowdenMobile$22K
- David DonahoeMobile$21K
- Albert HaasMobile$19K
- Jeffrey BrewerMobile$18K
- Robert HulickMobile$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.